Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence

Simple item page
dc.contributor.authorShearer, James
dc.contributor.authorShanahan, Marian
dc.contributor.authorDarke, Shane
dc.contributor.authorRodgers, Craig
dc.contributor.authorvan Beek, Ingrid
dc.contributor.authorMcKetin, Rebecca
dc.contributor.authorMattick, Richard P
dc.date.accessioned2015-12-13T22:44:03Z
dc.date.issued2010
dc.date.updated2016-02-24T09:38:05Z
dc.description.abstractIntroduction and Aims. To examine the cost-effectiveness of modafinil (200 mg daily) plus counselling compared with placebo for the treatment of psychostimulant dependence. Design and Methods. Cost and outcome data were collected alongside two randomised
dc.identifier.issn0959-5236
dc.identifier.urihttp://hdl.handle.net/1885/79480
dc.publisherCarfax Publishing, Taylor & Francis Group
dc.sourceDrug and Alcohol Review
dc.subjectKeywords: benzhydryl derivative; central stimulant agent; modafinil; adult; article; clinical trial; cocaine dependence; controlled clinical trial; controlled study; cost benefit analysis; counseling; drug abuse; economics; female; health care cost; human; male; mi Cocaine dependence; Cost-effectiveness; Methamphetamine dependence; Modafinil; Psychostimulant treatment
dc.titleA cost-effectiveness analysis of modafinil therapy for psychostimulant dependence
dc.typeJournal article
local.bibliographicCitation.issue3
local.bibliographicCitation.lastpage242
local.bibliographicCitation.startpage235
local.contributor.affiliationShearer, James, University of Exeter
local.contributor.affiliationShanahan, Marian, University of New South Wales
local.contributor.affiliationDarke, Shane, University of New South Wales
local.contributor.affiliationRodgers, Craig, Sydney Hospital
local.contributor.affiliationvan Beek, Ingrid, Sydney Hospital
local.contributor.affiliationMcKetin, Rebecca, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationMattick, Richard P, University of New South Wales
local.contributor.authoruidMcKetin, Rebecca, u5065925
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111700 - PUBLIC HEALTH AND HEALTH SERVICES
local.identifier.absseo920414 - Substance Abuse
local.identifier.ariespublicationf5625xPUB7913
local.identifier.citationvolume29
local.identifier.doi10.1111/j.1465-3362.2009.00148.x
local.identifier.scopusID2-s2.0-77957332706
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Shearer_A_cost-effectiveness_analysis_2010.pdf
Size:
439.8 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS